Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy.
- Published In:
- Journal of peptide science : an official publication of the European Peptide Society, 30(10), e3607 (2024)
- Authors:
- Aloj, Luigi, Mansi, Rosalba, De Luca, Stefania, Accardo, Antonella, Tesauro, Diego, Morelli, Giancarlo
- Database ID:
- RPEP-07732
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07732APA
Aloj, Luigi; Mansi, Rosalba; De Luca, Stefania; Accardo, Antonella; Tesauro, Diego; Morelli, Giancarlo. (2024). Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy.. Journal of peptide science : an official publication of the European Peptide Society, 30(10), e3607. https://doi.org/10.1002/psc.3607
MLA
Aloj, Luigi, et al. "Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy.." Journal of peptide science : an official publication of the European Peptide Society, 2024. https://doi.org/10.1002/psc.3607
RethinkPeptides
RethinkPeptides Research Database. "Radiolabeled peptides and their expanding role in clinical i..." RPEP-07732. Retrieved from https://rethinkpeptides.com/research/aloj-2024-radiolabeled-peptides-and-their
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.